August 19, 2010 by Chain Drug Review
Issue 08-16-2010, News
RALEIGH, N.C. — Former pharmaceutical company executive Richard Domann has joined Kerr Drug’s Kerr Health subsidiary. Domann, who has more than three decades of experience in the drug industry, is the company’s vice president of sales and business development. “Dick’s immense pharmaceutical background makes him a wonderful addition to our team,” Kerr chief executive officer
August 19, 2010 by Chain Drug Review
Issue 08-16-2010, News
NEW YORK — Expectations for back-to-school spending may be up or down this year, depending on which consumer survey is consulted. But retail pharmacy operators who provide walk-in clinics are looking to capture business from pre-college and college students requiring physical exams and immunizations before heading back to class. The outlook for back-to-school (B-T-S) and
August 19, 2010 by Chain Drug Review
Issue 08-16-2010, News
WASHINGTON — John Castellani has been named president and chief executive officer of the Pharmaceutical Research and Manufacturers of America. Castellani, who will assume his new role September 1, joins PhRMA after more than nine years as president and chief executive officer of the Business Roundtable, a leading association of chief executive officers. He will
July 9, 2010 by Chain Drug Review
Issue 07-19-2010, News
CAMP HILL, Pa. — A day after Rite Aid Corp. chief operating officer John Standley took the reins as the drug chain’s president and chief executive officer, the company named senior executive vice president of merchandising, marketing and logistics Ken Martindale as its new chief operating officer. In his new position, the 50-year-old Martindale will
July 9, 2010 by Chain Drug Review
Issue 07-19-2010, News
DEERFIELD, Ill. — Later this summer Walgreen Co. plans to give its customers a taste of Duane Reade’s successful private label program as it continues to ramp up its food offering. Beginning in August, Walgreens stores chainwide will offer an initial selection of Duane Reade’s Delish private brand consumables, Walgreens chief executive officer Greg Wasson
July 9, 2010 by Chain Drug Review
Issue 07-19-2010, News
ALEXANDRIA, Va. — Building on the pharmacy-specific provisions in the health care reform law, the National Association of Chain Drug Stores and the National Community Pharmacists Association (NCPA) have endorsed medication therapy management (MTM) legislation. The MTM bill was authored and introduced by Sen. Kay Hagan (D., N.C.) with Sen. Al Franken (D., Minn.) as
July 9, 2010 by Chain Drug Review
Issue 07-19-2010, News
BENTONVILLE, Ark. — Walmart has made several changes in its management ranks in recent weeks. The biggest of those changes has been the appointment of Walmart U.S. chief operating officer Bill Simon to president and chief executive officer of the domestic unit. The 50-year-old Simon takes over from Eduardo Castro-Wright, who had headed the United
July 9, 2010 by Chain Drug Review
Issue 07-19-2010, News
LANGLEY, British Columbia — The Canadian drug chains Pharmasave and Rx PharmaChoice have formed a strategic alliance that executives say will strengthen both companies. The partnership between the two franchise operations will be known as PharmAlliance and will help the independent stores across the country that operate under the Pharmasave and PharmaChoice banners become more
July 9, 2010 by Chain Drug Review
Issue 07-19-2010, News
WASHINGTON — After the confirmation of President Obama’s choice to run the Centers for Medicare and Medicaid Services (CMS) was held up for nearly three months by Republicans, the president bypassed the legislators earlier this month and appointed Donald Berwick to the post while the Senate was on its summer recess. Obama had nominated Berwick
July 9, 2010 by Chain Drug Review
Issue 07-19-2010, News
LONGUEUIL, Quebec — Jean Coutu Group, which posted increased profit in the first quarter, is waiting to see how provincial drug reform will affect its future earnings. Coutu posted a profit of $43.2 million (Canadian) for the fiscal quarter ended May 29, an increase of 12.2% compared with the prior-year period. Revenue increased 3.8% to
July 9, 2010 by Chain Drug Review
Issue 07-19-2010, News
ALEXANDRIA, Va. — The National Community Pharmacists Association (NCPA) and the Chain Drug Consortium (CDC) have formed a collaboration that they say will leverage the strengths of each organization and advance the interests of community pharmacists and their patients. CDC provides its retail members with programs, services and purchasing power to help family-owned and privately
July 9, 2010 by Chain Drug Review
Issue 07-19-2010, News
CAMP HILL, Pa. — Rite Aid Corp. has launched the latest phase of its revamped private label program with the debut of Simplify, a store brand aimed at price-sensitive shoppers. The initial products in the line consist of two-ply paper towels and one- and two-ply bath tissue as well as strawberry- and berry-flavored drinks and
July 9, 2010 by Chain Drug Review
Issue 07-19-2010, News
WASHINGTON — Health care reform is being viewed more favorably following the Obama administration’s rollout of multiple regulations laying the groundwork for the law’s implementation. New rules that affect health insurance include permission for young adults to stay on their parents’ policies and a prohibition on denying coverage to children who have preexisting conditions. The
June 25, 2010 by Chain Drug Review
Issue 06-28-2010, News
NEW YORK — Walgreen Co. and CVS Caremark Corp. have settled their fight over pharmacy benefits management. Walgreens will continue participating in the CVS Caremark retail network for current, new and renewed plans, the companies announced. They did not disclose the financial terms of their new contract. “We are very pleased with the outcome of